Information & Resources

Find information and resources to help manage your pain.

Get Help & Support

Find the tools you need to
help you manage your pain.

Get Involved

Help make a real difference to people
in the UK living with chronic pain.

About Us

Find out about Pain Concern and how
we can help you.

WE NEED YOUR HELP:

We are going to be performing an evaluation of our magazine, Pain Matters, over the course of the next few months. Evaluation is a key factor in securing funds, not just for future issues of Pain Matters, but to fund all the work we do here at Pain Concern.

If you are a Pain Matters reader – whether you are a person living with pain, a healthcare professional or just have an interest in chronic pain – we would be extremely grateful if you can complete and return the short questionnaire which will be included with the next magazine. Alternatively, you can visit survey.painconcern.org.uk and complete the online version. It should only take about five minutes and your responses will help us to continue producing the variety of resources we produce.

 HELP US TO HELP OTHERS

INSIDE THE MULTIDISCIPLINARY PAIN TEAM

Happy New Year from all of us at Pain Matters. In our first magazine of the new decade, we have invited the Chronic Pain Team from NHS Borders in the south of Scotland into the guest-editor’s chair for issue 74. In a jam-packed issue, they have looked at everything from the Pain Management Jigsaw, which tries to bring together all the different aspects of managing pain, to the role of occupational therapy and how laughter can be a tool in the pain management toolbox.

Also in issue 74, Vidyamala Burch returns with her Being Mindful column, giving her three reasons why mindfulness is helpful for ‘living well with pain’.

OUT NOW

Click HERE to buy or Subscribe 

Half a century worth of research exists on neuropathic pain but what are the latest developments? 

This edition of Airing Pain is facilitated by the neuropathic pain special interest group (NeuPSIG) of the International Association for the Study of Pain (IASP).

With the previous edition of Airing Pain focusing on the ‘psycho’ and ‘social’ of the bio-psycho-social model, this programme tackles the ‘bio’ component.

In this second instalment in a mini-series on neuropathic pain, Paul Evans delves into the latest scientific developments on the condition and the ways in which the gap between research and treatments could be bridged.

Following on from Airing Pain 115, which concentrated on targeted Pain Management Programmes, this edition discusses the ‘bio’ element on dealing with neuropathic pain. Speaking to Professor Srinivasa Raja, Paul discusses what exactly is going on in the brain with neuropathic pain. Professor Raja provides a valuable explanation of the science behind the condition.

Patrick M. Dougherty, Professor at the Department of Pain Medicine at The University of Texas MD Anderson Cancer Centre then shares with Paul the latest advances in neuropathic pain research. He examines the link between cancer treatments and the condition as well as the potential for treatments such as immunotherapy to combat neuropathic pain in the future.

Issues covered in this programme include: Neuropathic pain, the bio-psychosocial model, allodynia, nerve injury, post-herpetic neuralgia, pain after shingles, pain after amputation, differences between men and women, chemotherapy-related pain, cancer, multidisciplinary pain teams, and personalised pain management therapies. 


Contributors:

  • Patrick M. Dougherty, Professor at the Department of Pain Medicine, Division of Anaesthesiology and Critical Care, The University of Texas MD Anderson Cancer Centre, Houston.
  • Professor Srinivasa Raja (John Hopkins School of Medicine, USA).

More information:

AIRING PAIN 121: LIVING WITH PERSISTENT PAIN IN WALES

Listen to the trailer below

AVAILABLE TO LISTEN OR DOWNLOAD FROM TUESDAY 3 MARCH 2020

(VIA THE PAIN CONCERN WEBSITE, APPLE PODCASTS, SPOTIFY OR WHEREVER YOU GET YOUR PODCASTS)


Programme details:

In April 2019, the Minister for Health and Social Services in Wales launched the guidance document Living with Persistent Pain in Wales. Later, in December, the Chronic Pain Policy Coalition brought together some of Wales’s leading pain experts at the home of the Welsh parliament (or Senedd Cymru) in Cardiff, at an event chaired by Neil Betteridge, co-chair of the Chronic Pain Policy Coalition, a group which brings together a wide range of chronic pain stakeholders including professional bodies, patient organisations, parliamentarians and industry representatives from across the UK.

This edition of Airing Pain was recorded live at the event, where clinicians, academics, policy-makers and people living with pain came together to discuss both the new document and the future of chronic pain services across the region.


Contributors:

  • Neil Betteridge, Co-Chair, Chronic Pain Policy Coalition
  • Dr Paul Cameron, Specialty Advisor to the Chief Medical Officer for Scotland
  • Professor Ernest Choy, Head of Rheumatology, Cardiff University
  • Mary Cowern, Wales Director, Versus Arthritis
  • David Easton, Physiotherapist, Hywel Da NHS Trust
  • Dr Lucy Morris, GP partner, Bellevue Practice, Newport
  • Professor Ann Taylor, Professor in Medical Education, Cardiff University.

More information:


Exploring neuropathic pain and the various ways it can be managed

To listen to this programme, please click here.

In this edition of Airing Pain, Paul Evans investigates the ideas behind Pain Management Programmes, and highlights the importance of the patient in shaping their own treatment.

Internationally recognised Professor Srinivasa Raja speaks to Paul about the differences between nociceptive and neuropathic pain, as well as the complexities of chronic pain and its management.

Consultant Clinical Psychologist, Dr Clare Daniel examines the psychological and social components of chronic pain. She discusses the important role of the cognitive behavioural model in Pain Management Programmes.

Paul speaks to lead physiotherapist Diarmuid Denneny about the importance of the patient in determining the appropriate response to their pain, by taking into account their life and personal aspirations.

Finally, Cameron Rashide, a patient with neuropathic pain among other conditions, speaks of the pain management technique ‘pacing’ and how she has learnt to manage her pain through pushing herself ever so slightly outside her comfort zone.

Issues covered in this programme include: After a stroke, post-herpetic neuralgia, shingles, post-surgical pain, brain signals, emotions, exercise, loss of sensation, mindfulness, nervous system, neuropathic pain, nociceptive pain, numbness, pacing, psychology, tissue injury and trigeminal neuralgia.

Paul Evans: This is Airing Pain, a programme brought to you by Pain Concern, the UK charity providing information and support for those of us living with pain, and for healthcare professionals. I’m Paul Evans.

Clare Daniel: A good pain management programme is about responding to what the people bring. So when I was really interested in setting up a programme for people with neuropathic pain, people said to me, ‘Why are you doing this on diagnosis?’

Diarmuid Denneny: It’s well known that people with neuropathic pain wouldn’t tend to do as well on our general pain management programmes. Their outcomes from all the different measures weren’t as good, or as expected.

Daniels: I wanted to do it because of the differences I observed tailoring our intervention to what they were coming with.

Evans: Neuropathic pain is caused by nerve damage or nerve disease. It’s often described by those who have it as burning, aching, or like an electric shock. Many experience pins and needles, numbness and weakness. For some, it’s a stabbing pain in the middle of the night. For others, it’s a burning feeling felt throughout the day. Amongst other causes, it can be caused by shingles, diabetes, surgery or a stroke.

In May of this year, that’s 2019, the International Association for the Study of Pain brought together the world’s leading experts on neuropathic pain in London to share experience and knowledge. One of those is Professor Srinivasa Raja of Johns Hopkins School of Medicine in Baltimore in the United States. He’s internationally recognised for his research into neuropathic pain.

Srinivasa Raja: The International Association for the Study of Pain defines it as pain that results from a disease or injury that affects the somatosensory system. And that big term ‘somatosensory’ actually just means anywhere in the pain signalling process, from the periphery, which could be at the level of the skin, to the brain. The injury or the disease can affect anywhere in that process. Some good examples would be pain that persists after shingles, or herpes zoster, what we call a post-herpetic neuralgia; or a condition after a spinal cord injury; or after a stroke. So here we see that, like in herpes zoster, it’s initially a skin legion that affects the peripheral nervous system. In spinal cord injury it’s the spinal cord, but in stroke it’s the brain. So all of these, or injuries anywhere along this nervous system can lead to neuropathic pain.

Evans: The other term I’ve heard is nociceptive pain, how does it differ from that?

Raja: Nociceptive pain is that pain that could result from an actual or potential injury to tissues. Could be as simple as a pinprick, it could be a burn, or after a surgery, the immediate pain after surgery. So this is usually associated with a tissue injury mechanism.

In contrast, neuropathic pain specifically involves an injury to the nervous system. So, the main difference is what initiates and what causes the pain. But the patients also describe the pain differently, often. The neuropathic pain, there could be an area where the patient says, ‘I’m numb’, but immediately adjacent to it, even touching that area causes pain. So, this kind of challenging situation, where there is loss of sensation as well as amplified, or increased, sensation that coexists is typical for neuropathic pain.

Evans: So if I bang my finger, hurt my finger, that hurts, that sends messages up to my brain that he’s just banged his finger and the brain will translate that into pain. But that pain will go. It will heal. [Yes]. Neuropathic pain stays?

Raja: Not all neuropathic pain stays chronic. There may be some situations which we now call acute neuropathic pain, where the pain may gradually disappear with time. A good example of that may be the phantom pain that usually occurs after an amputation. Most patients, immediately after the surgery, or after the injury, will experience that sensation of pain in the missing part of the limb. However, the majority of those patients seem to resolve in time, it’s only a smaller subset of those patients who persist, and go on to chronic pain.

So the good thing about it is it seems that the body has some protective functions, and in most cases, fortunately for us, the pain resolves with time. It could be weeks to months. But in some cases these pain states persist, and it is this chronic pain state that becomes problematic to most patients.

Evans: So how do you deal with that?

Raja: One of the first aspects of dealing with patients with chronic pain is an appropriate assessment of their problem. An assessment includes not only the description of the pain experience, how they perceive it, but also functionally how this pain affects their quality of life, their day-to-day functioning. In most cases also examining the psychosocial comorbidities, one of the most interesting things is that the pain experience is different from individual to individual given the same injury, and therefore one has to assess what are the other environmental psychosocial factors that may also contribute to this chronic pain experience.

Evans: They call that the biopsychosocial model for pain, where everything around us, our bodies, our society, things that happen in the street and at home, everything feeds in to the pain.

Raja: A few decades back, neuroscientists, people trying to understand the pain mechanisms, thought that this was purely a biological mechanism. That there was injury to tissues, there were certain nerves that were excited, which resulted in the sensation of pain. What we have learned over the last several decades is that it’s much more complex, and that the experience of pain is modified, or modulated, as we call it, by a number of factors. It could be genes, it could be psychological environment, social environment, their prior experiences, and so it’s much more complex that a sensation or just trafficking or signals that go along pain pathways.

Evans: That’s Professor Srinivasa Raja of Johns Hopkins School of Medicine in the United States. We’ll be talking in greater detail about his, and others’, research about neuropathic pain in a future edition of Airing Pain. But in this edition I want to concentrate on those psychological and social components of chronic pain.

Doctor Clare Daniel is a Consultant Clinical Psychologist. Now leading psychological services at Buckinghamshire Healthcare NHS Trust, she previously worked at the National Hospital for Neurology and Neurosurgery Pain Management Centre in London.

Daniel: Psychologists tend to work with the cognitive behavioural model on different variations, and actually, the physiotherapists do as well, if they’re working in pain services. So the cognitive behavioural model, if you just picture a cross, on the four ends of the cross there are four words. One is thoughts, one is emotions, one is behaviour and the other is body. Ok, so thoughts, emotions, behaviour and body, and the idea is that they are all influencing each other. If a person’s fearful, their emotion is fear and they have chronic pain, the chances are that fear is going to turn up the volume, or the intensity of that pain. So that person needs to have input from a body practitioner, which might be a physiotherapist, but obviously thinking psychologically, but also a psychologist. Because you need to address the thoughts and the emotions, which is the psychology part of it, and the behaviour and the body, which is the physio part of it. But in an integrated way, because if you go to a non-pain service you’ll often get the psychologist that will just focus on thoughts and emotions and the physios that just focus on body and behaviour.

Evans: So it’s thoughts, emotion, behaviour and body.

Daniel: It’s just getting people to think about the likelihood of the influence, because actually, one cognitive behavioural model, which is acceptance and commitment therapy, is really trying to separate thoughts and emotions from behaviour. So regardless of what you’re feeling in terms of emotions about your pain, so ‘I’m really frightened about my pain, I can’t do something’, the intervention is to try and keep going with the behaviour, because it fits in with your values.

It’s about thinking about the interaction between the four, and in some respects can you just loosen that interaction. A classic example with neuropathic pain is even if people just experience the sudden electric shock type pain, trigeminal neuralgia (TN) is a classic example, they can be pain free for a long time, but their pain is still massively impacting on them during pain free times. A lot of the time it’s because of the thought, ‘well if I go outside, and if I get a sudden shock of TN, I might be stranded, no-one’s going to help me, I can’t get home, I might not have my tablets’. So it’s that fear and that prediction that make them stay, understandably, at home.

Evans: I would think that’s a perfectly natural way to think. ‘I won’t go out today, what happens if I have a flare up away from home?’

Daniel: I always say when I work with people, is that their responses to their pain are totally natural and understandable. Because acute pain is a warning sign; it’s signalling danger. Chronic pain, it’s not, but that’s how our bodies and brains are wired, to see pain as a danger. So therefore of course we’re going to want to protect ourselves, and not put ourselves in danger.

But we have to change that link or belief with chronic pain, that it’s pain but it’s not dangerous. And we can help you to build up your confidence, to manage the pain if you go outside today.

Evans: Clare Daniel.

Diarmuid Denneny is Physiotherapy Lead at the National Hospital for Neurology and Neurosurgery Pain Management Centre in London.

Denneny: The main role of physiotherapy in pain management, whether it’s neuropathic or another type of chronic pain, is around helping people to understand the pain, why the pain lasts, why it hasn’t gone away. And there are often key messages that we would weave into that part of our work, which are around, it’s possible to experience pain even though the body is no longer experiencing damage, or being damaged. And that the amount of pain that we feel doesn’t necessarily equal the amount of injury that our body has, if it was injured, sustained.

So around the understanding of the pain, and in order to do that we need to understand the person and their life, and what’s important to them, and what the pain is stopping them from doing. So that we can start to work out, and I should say we work very closely with psychologists in pain, so we try to work out what’s important to the person who is experiencing the pain, that they are no longer able to do, or that they find difficult to do. And to work out ways to do that, and that’s when we start to think about the physical activity, or the ability to do things. And there’s a reality that most people, by the time they get to meet with a physiotherapist who specialises in pain, will have encountered many physios before that – an average of four or five is a figure I’ve often heard. And so they understandably come somewhat wary or reticent – this idea [of] ‘not another physiotherapist’. Often they’ll have tried to do things with physio and they may have experienced their pain increasing or getting worse, not getting rid of the pain. So the work we do might be to help people to understand that although they’re here because of pain, we might shift our focus more to what they want to be able to do, and look at ways to do that. Which may include looking at movement, and how to move in a way that allows them to build up their activity levels. And activity levels doesn’t necessarily mean going to a gym or doing a prescription of exercises, it can be being able to hang up the washing at home, or to play with their grandkids, or to do their work, which might include an element of physical activity, standing all day, or whatever it is. So we try to explore a bit about activity and exercises, not just going to a gym, but looking at things that fit into their lives.

Evans: I guess something as simple as getting out of bed is an activity?

Denneny: Absolutely, because the centre here is a specialised pain service, so we’ll often see people who’ve been to other pain services first. And their activity levels can be really, really, really affected by pain. Many people will say they have to spend all day in bed with pain, so a starting point might be thinking about sitting up in bed.

Evans: That was physiotherapist Diarmuid Denneny.

Cameron Rashide: It’s been eight years since I’ve stopped working. In the last eight years I literally stayed at home because the pain is too much for me. I stopped going out to coffee shops, and wouldn’t go out shopping on my own ­– everything online. Literally it was: hospital, home, hospital, doctor, hospital, home.

Evans: Cameron Rashide is a participant on the COPE pain management programme at the pain management centre in London. COPE is group based and focuses on self-management, building upon skills to help people reduce the impact that pain has on their lives.

Rashide: It’s basically living, breathing with your chronic pain. Even though you’re in pain, don’t think that the pain takes you, you take the pain. You have to decide what you can do with it.

Evans: How do you do that?

Rashide: So basically, on this we’ve learnt different skills, we’ve learned to pace ourselves, we’ve learned to cope with feelings and structures. So you have the thought, the feelings and the behaviour. The thought always will be – ‘I can’t do this, I don’t think I can do this’. The feelings will be – ‘ok I want to do this, but can I do this?’. So then the behaviour is actually putting them two in action, and adding the ‘and’ into it, and saying ‘I think I can do this, but if I try this and I try this, I can get to…’ In other words, instead of saying A-to-B, you can’t get there on its own, you need the ‘C’ there, so it’s trying to put them all together.

Learning the skill of just pushing yourself just a little bit, but not too much. Pacing. The golden word, pacing.

Evans: That’s the theory. How are you putting it into practice? And how’s it affecting you?

Rashide: There’s other skills, they’ve asked us to go outside the box that you normally would do since you’ve been in pain. Now this has taught us to practically do something outside the box, like last week my weekly goal was to go to a coffee bar, and I did that. Even though I wasn’t comfortable, I was in pain, but it was enough to pace myself, but not overdo it. So it’s little goals, but achievable goals.

Evans: Well, amongst other conditions, like fibromyalgia, Cameron has neuropathic pain. But there’s a growing body of evidence that people with neuropathic pain don’t do as well on general pain management programmes as those who have other chronic pain conditions. Clare Daniel.

Daniel: I was quite new to pain services and I hadn’t quite realised the difference between neuropathic pain and non-neuropathic pain. And I noted this group of patients, they didn’t quite do as well in the programmes. Some people left the programmes, dropped out, because they just felt as though what we were saying didn’t fit with their experiences. So, ‘I’m different from everybody else in the programme’. And then I began to realise that ‘Well, these are often people with neuropathic pain’. So I looked at the differences between a group of people with non-neuropathic pain and people with neuropathic pain, and actually the main difference is the pacing can help, but doesn’t necessarily help them. Please don’t think I’m saying ‘Don’t pace at all’ because it can be very helpful, but some people don’t feel as though it’s helpful, or it’s unpredictably helpful. And the other thing is the sudden pain that just suddenly comes on. So my gut instinct at that point was that if they can begin to respond differently to their sudden pain, as opposed to what often happens of sometimes literally falling to the floor, or curling up in a ball, if they could stay in the present, remain mindful, learn strategies just to keep them present. Not become very fearful about ‘My pains suddenly there, what’s going to happen?’. Begin to respond, I guess much more gently on themselves, and differently.

Denneny: Asking people with neuropathic pain what would be helpful, and they did express wanting to understand more about the nuts and bolts of the nervous system and how that might be contributing to their pain. So I suppose broadly we agree that it would be helpful to go into more detail on that aspect of the body as part of the programme. So if we call it psychoeducation, we thought that would be useful to include in the programme. Mindfulness uses a certain type of language – if you think about neuroplasticity, which is, broadly speaking, the way that the nervous system is constantly adapting to its environment, and the effect of the environment on the nervous system. So it’s always changing all the time, which is to me tremendously hopeful [laughs].

A lot of the factors that are most helpful for the nervous system, in terms of that neuroplasticity, are around novelty, are around being engaged in a community; so going out and about. They’re around repetition; they’re around focus. And if you think about that in the language of mindfulness, it’s saying the same things really, in terms of what you do. So we thought maybe it would be useful to apply some of those strategies within a programme. So that’s what we set up, and we piloted it for the first three or four weeks [cut off] – 20 patients – and we found that their outcomes, whereas previously they were slightly below what we would have expected, they kind of matched, or exceeded the general scores that we would expect.

Daniel: Astounding in a couple of cases, I remember.

Evans: So basically, the difference between a neuropathic pain management programme and a non-neuropathic pain programme is just how to handle the different ways that pain comes?

Denneny: So around these sudden, severe episodes of pain, feedback almost consistently is actually, the most helpful thing in those moments is to bring my awareness to my breathing. Because it’s a reality with these that they are very sudden, severe, quick, and then they go away almost as quickly as they’ve come. And by the time you’ve got to your medication or other things that might be helpful, it’s settled back down again. So in terms of responsiveness, we’re always carrying our breathing with us all the time, so it’s something that we have access to and we can drop into.

It doesn’t work for everybody, it’s important to point that out, it’s not a panacea or something that is going to work for everybody, but for those who’ve come on the programme, that’s the one thing that they tend to really value and find helpful. So there’s something about strategies and the symptoms that people experience, and then there’s something about the information that we give on it is perhaps more information than you might think is helpful on a general programme. We always give people resources and they’re free to read as much or as little as they want to, or to explore as much or as little as they want to, but we’ve found people with neuropathic pain, they tended to want to know more about what’s going on in the nervous system, how does it change, why does it change, and how does it explain these symptoms.

Daniel: A good pain management programme is about responding to what the people bring. So when I was really interested in setting up a programme for people with neuropathic pain a lot of people said to me, ‘Why are you doing this on diagnosis?’. Of course, I was, because I was separating neuropathic pain from non-neuropathic pain, but that’s not the reason why I was doing it. I wanted to do it because of the differences I observed, so what people were coming with. They could have been diagnosed with anything, but it didn’t really matter to me, it was about tailoring our intervention to what they were coming with.

Evans: This is a very broad question, but what would you consider to be a successful treatment?

Denneny: It’s really down to the person with pain to decide that. In the days of Alastair Campbell I used to think we were trying to help spin things a little bit, by saying ‘Ok you’re here because of pain but we want to focus on what’s important to you’. And in a sense that is what we’re doing, so success would look like somebody achieving the goals that they’d set themselves during their time with us. And maybe not even during their time with us, but having on their last session a very clear ‘I’m not there yet but I know what I have to do, and this is my plan to get there’.

Evans: Establishing what goals a person sets for himself or herself – that can be a very difficult thing because somebody coming to a specialist unit like this might think, well, ‘My goal is to climb Everest’, ‘My goal is to do the London marathon’. How do you sort out expectations?

Daniel: When I first starting working in pain, which was a long time ago, we just focussed on goals and people did find that very difficult, particularly people from different cultures with English as a second language, a goal might mean something very different. More in the last seven to ten years we’ve talked much more about values. And values are some things that are really important to us, and it might be developing, learning, health – they tend to be one word. So it’s about something that we’re continuously aiming towards in our life. We never actually quite reach them, we’re just continuously going towards those.

And then goals are shorter steps in the pursuit of those values, in line with those values. In terms of realistic goals, we talk about short term and long term goals, because as Diarmuid said, when people finish the programme it’s not finished, they will continue, hopefully, to improve in terms of quality of life, reducing the impact of pain. So we’re very clear about short term steps. We do talk a lot about the fact that that might be frustrating to people because they want to get up and run, run before they can walk, literally sometimes. And we do talk very much about realistic expectations. When we talk about goals we talk about SMART goals, the acronym SMART.

Evans: SMART is?

Daniel: So, S stands for specific, so a very specific goal – so not just, ‘I want to swim’. It might be ‘I want to swim two lengths three times a week’. It doesn’t matter. It’s absolutely set by the person with pain. It’s not set by us. So – specific. Measurable, so that you know when you’ve achieved it: so the number of lengths that you want to, for example, swim. Achievable – think about this, is it really achievable with what you’ve set in the timeframe that you’ve set it, ‘Can I swim two lengths by, let’s say six weeks’ time?’. And then the R could be, people often say realistic, personally I think that’s quite similar to achievable. I think relevant’s quite a good one, so ‘Is it relevant to me? Does it fit with my values? Does it fit with what I want to achieve in life? Is it relevant to me?’. And then the T is timeframe or time bound, so ‘When do I aim to achieve this goal by?’. But we’ve also started to talk about that having to be flexible, so we often put an F on the end of SMART [laugh], because people do have high expectations of themselves, they can get very frustrated, life can throw things at them and the measures, or the timeframe that they’ve set for their goals can go awry. And that’s quite normal, that’s life, so we help them to be flexible and think, ‘Well, ok, if you need to push that back a bit, that’s fine’. But what we don’t want is for them to keep pushing back and back and back and never achieve.

Denneny: With pain there’s this idea that doing something that you want to do, that’s important to do, often that you have to do, just because real life means we have to do things, afterwards experiencing an increase in pain. Some people call that boom bust cycle, some people talk about activity cycling, where they do more and then have a period of not being able to do as much. We talk a lot here about flare ups or pain flares. This is terminology, different people have their own preference for what they want to call that. And I suppose for us, working with people with pain, the important thing is to acknowledge that they’re [flare ups/pain flares] a normal part of living with long term pain. They will happen. They don’t mean that things are necessarily getting worse because they are a normal part of the condition over time. And so the challenge is, and what we work a lot on with people, is learning ways to manage, as best they can, so that they get through these flares without having an impact on their ability to manage that sets them back.

Daniel: But also, specifically with neuropathic pain, I think it’s important to help people understand that neuropathic pain, for a lot, not everybody, it can come suddenly. It just suddenly happens with no specific warning. Whereas non-neuropathic pain, not always, but it can just gradually increase and the person knows it’s beginning to increase. So, it’s important that the person recognises that a sudden increase in their neuropathic pain is actually normal. That’s not necessarily related to the boom and bust activity cycling.

Denneny: That is really important, yeah. And again going back to what we do with people, it’s to help try and separate what the pain is doing from what they do day-to-day. Because more than any other group that we work with, people who have neuropathic pain really struggle because often the classic is, ‘Well it doesn’t matter what I do, it’ll either hurt a lot if it’s hurting a lot’, or ‘It doesn’t make any difference’ so much.

So, some of our more, what could be considered traditional strategies for working with people with chronic pain, people who have neuropathic symptoms often struggle, particularly pacing.

Daniel: Yeah, because pacing can be quite, less so nowadays, but it can be quite prescriptive. In the olden days it used to be about people increasing their activity levels, mainly within time. So it might be that you walk for one minute, have a rest, then walk for another minute, and gradually over days, weeks, months, increase that. But some people with neuropathic pain say, ‘Well that doesn’t make sense to me. Regardless of what I do, regardless of how far I walk, even if I’m just sitting down and not walking, my pain will suddenly increase. But sometimes I can walk five minutes and its fine’. So pacing for some people makes less sense, but I think the message therefore has to be a bit more flexible and it’s about, ‘It’s safe to move’. Your pain will increase at times, but then what can you do when it does increase, to help yourself, either mood not suddenly plummet, or giving yourself a hard time.

Denneny: Or stopping doing something because, unfortunately, has it happened at the time you were doing something and you’ve made that link that doing that is what caused it, which isn’t always true.

Evans: That’s physiotherapist Diarmuid Denneny and psychologist Clare Daniel.

For more information about pain services at The National Hospital for Neurology and Neurosurgery Pain Management Centre, including their pain management programmes, put the letters U, C and L, that’s University College London, with the words ‘pain management centre’ into your search engine.

I’ll just remind you as I always do, that whilst we in Pain Concern believe the information and opinions on Airing Pain are accurate and sound, based on the best judgments available, you should always consult your health professional on any matter relating to your health and wellbeing. He or she is the only person who knows you, your circumstances and therefore the appropriate action to take on your behalf.

Now, to end this edition of Airing Pain, what advice would the team give for those who don’t have access to a specific neuropathic pain management programme?

Denneny: There are lots of resources out there in terms of exploring things like mindfulness based pain management approaches they could look at. It’s being flexible with the pacing, or this idea of building up activity, that holding that lightly, if that’s possible. That it’s good to be active just generally for all sorts of other reasons.

Daniel: And safe, it’s safe to be active.

Denneny: It’s safe, yeah, really important.

Daniel: That’s a big important message, ‘I’m not going to do any more damage, I’m not going to do damage’. So a lot of the non-neuropathic principles absolutely apply to neuropathic. And I’d say this to any person with pain, if they’re accessing online resources or self-help materials, about taking what is useful for them.

Evans: And that it’s trusted.

Daniel: Yeah, an evidence based approach is absolutely essential.


Contributors:

  • Dr Clare Daniel, Consultant Clinical Psychologist, Buckinghamshire Healthcare NHS Trust
  • Diarmuid Denneny, Physiotherapy Lead at the National Hospital for Neurology and Neurosurgery Pain Management Centre in London
  • Professor Srinivasa Raja, Johns Hopkins School of Medicine, USA
  • Cameron Rashide, patient who lives with chronic pain.

More Information:

How we prevent, manage and diagnose this ‘silent disease’

To listen to this programme, please click here.

This edition of Airing Pain has been supported by a grant from The D’Oyly Carte Charitable Trust.

Osteoporosis is a largely ignored condition that affects over 3 million people in the UK, with women being more at risk; a condition which, because the symptoms are difficult to notice by patients, is often referred to as the ‘silent disease’. In this edition of Airing Pain, we learn why prevention, assessment and management are key factors to deal with this condition and develop a correct model of care in the health services.

 First-off, Paul Evans speaks to Dr Emma Clark, Consultant in Rheumatology & Osteoporosis at North Bristol NHS Trust, to find out about the causes and characteristics of osteoporosis. She discusses how osteoporosis can be ignored or misdiagnosed as osteoarthritis, as well as ways in which we can look after our bone health. Dr Clark also talks about how she is currently developing a clinical tool for primary care professionals to help them identify signs of osteoporosis when they meet with their patients.

Paul also speaks to Sarah Leyland, Nurse Consultant at the Royal Osteoporosis Society, about the new focus on prevention, mainly in terms of lifestyle changes and developing a model of care designed to identify people who are at higher risk of osteoporotic fractures. She also describes the range of physical exercises she has developed to reduce the risk of fractures and help with pain after fractures.

Issues covered in this programme include: Fractures, bone health, osteoporosis, osteoporosis prevention, osteoporosis symptoms, risk of fractures, spinal fracture, aging, elderly people, vertebral fracture, vertical fracture and weak bones.

Paul Evans: This is Airing Pain, the programme brought to you by Pain Concern, the UK charity providing information and support for those of us living with pain and for those who care for us. This edition of Airing Pain has been supported by a grant from the d’Oyly Carte Charitable Trust. I’m Paul Evans.

Emma Clark: Less than a third of people with osteoporotic vertebral fractures are being identified. If we can find people who have vertebral fractures, we can give medications to reduce the risk of future fractures. We can reduce the risk of a hip fracture by about half and that is so important because hip fractures for the individual can be a disaster.

Evans: Osteoporosis is a condition where bones lose their strength and become fragile. It’s sometimes referred to as the ‘silent disease’ because, although almost 3 million people in the UK are estimated to have it, few know that they do have it until that is they break a bone, most likely in their wrist, hip or spine. And according to the charity Age UK, there are more than 300,000 fractures every year due to osteoporosis. Emma Clark is Consultant Rheumatologist at Bristol’s South Meade Hospital. She’s also Reader in Rheumatology at the University of Bristol where she does research into osteoporosis.

Clark: As we get older, like many parts of our body, our bones age and with time they become thinner. Both the outside of the bone but also the struts, which make up the mesh-like structure inside the bone [become thinner]. And this means the bones become more fragile and easier to break. It is this combination of the thinner bones and the increased risk of them breaking that we call osteoporosis. Our bones develop obviously from the time we’re born, and they carry on [developing] through adolescence, through growth. Interestingly, even after we stop growing around fifteen or sixteen, our bones continue to strengthen up probably until [our] mid-twenties or late-twenties. At that point, that is what we call peak bone mass.

Evans: Let me go back to the beginning. It’s quite pertinent for me because my granddaughter has just broken her hand, or broken her knuckle, and she is seven years old. What they’ve explained is [that] it’s not actually real bone that she’s broken, it’s what might turn into a bone. So what is the development of a bone from early age?

Clark: So we’ve got different types of bones but generally our bones are laid down, actually, when we are a foetus. Inside the uterus the pattern of our skeleton is laid down as cartilage, and then it turns into bones as we age. Our bones finish growing, the cartilage finishes turning into bone at the time of adolescence (when we stop growing up in height). They can still thicken up, as I said, until our late-twenties.

It’s very interesting that your poor granddaughter has broken her knuckle, because actually childhood fractures are really common. They do not mean that that child is going to get osteoporosis. I think that’s really key. Probably 45% of girls and 30% of boys will break a bone before they reach adult height. It’s an indicator that they are doing activities; it’s more of a marker really of exposure to injuries. In some ways, it might be good because it means that these children are running around and doing activities. They’re being physical, which is what we want to encourage.

Evans: Well, that is quite encouraging because two of my grandchildren have just broken bones. One in the leg and one in the knuckle! So at the age of 30, you were saying, bones are fully grown, at their peak?

Clark: Yes, absolutely at their peak. Then they stay like that until we develop the natural age-related bone loss which is actually the same in men and women. But women have this little acceleration during the menopause. Of course, women are generally smaller than men anyway so women’s peak bone mass is lower than men’s. Then they have this period of accelerated bone loss around the time of the menopause. But both men and women do lose bone as we get older.

Evans: Why is that?

Clark: Our bones are not actually a rigid static machine that just stays there. You may not wish to know this, but every second, of every minute, of every day we have these cells living on our bones that keep them healthy. We have this really big cell called an osteoclast that wanders over the surface of the bone and takes out little bites. We don’t know necessarily why. But we wonder if it does it because it’s found a fatigued area, that’s a bit warm perhaps or has got a microcrack in it. We don’t really know. Then behind it, along come these other cells called osteoblasts that fill it in again with new bone. Our skeleton is continuously bubbling along!

We have got these cells maintaining our bone health and we think that with age the osteoblasts – that build bone – just get a bit old; they don’t do what they used to do. The osteoclasts – that take the bites out – continue, but the osteoblasts are no longer quite so efficient; they don’t fill it in quite so well. The net effect of this is that our bones generally become a bit thinner.

Evans: Well, the next questions is ‘does osteoporosis mean pain?’

Clark: I think that’s a really, really important question because, on its own, osteoporosis is painless. You don’t know that you have osteoporosis, because it has no symptoms. It becomes painful only when you break a bone.

Evans: Which bones are right in the front line of risk?

Clark: We know there are a cluster of broken bones that are more likely in people with osteoporosis. These are the wrist, the forearm (you might have heard it called the Colles fracture), the upper arm (the humerus, the top of it, near the shoulder), the hip and a bone in the back (the vertebral body). They break in different ways: the hip, forearm and upper arm snap. You can think of it like a twig being broken. Whereas, the bone in the back does not snap in half. Instead, that is like if you imagine a piece of coral on the beach and you stand on it, it can crush down a little bit. That’s a process that starts gradually. They change shape – going from a rectangular shape to more of a triangular shape because the front of the bone squashes down and that is a broken bone.

Evans: Do you mean that they’re sort of crumbling?

Clark: No, I don’t think the bones are crumbling away because that suggests, in my mind, fragmentation or bits of them falling off. My impression from speaking to patients in clinic is that people have used the term crumbling bones to also mean osteoarthritis, which is a completely separate disease to osteoporosis. Osteoarthritis is the wear and tear arthritis where our joints become worn with age. That is completely separate to osteoporosis, which is purely about risk of fracture.

Evans: How does one fracture a bone in the vertebrae?

Clark: Well, actually, we don’t really know. We don’t have the full answers. We have got stories from patients. A typical story might just be something simple like reaching up into a cupboard or reaching up outside to hang some washing on the line. And a sudden sort of twinge in the back. Patients describe being outside walking and stepping off a high kerb. It’s just the jarring nature again of a pain in the back. But not every patient knows when they have broken a bone in their back because, in some people, it’s not necessarily that painful.

Another typical story actually is moving those great big black bins that the lorries pickup. A typical thing is that a patient describes pulling it up the drive and then trying to twist and pull it into the little cupboard where it’s meant to go. And that twisting [and] pulling of a quite heavy thing causes sudden pain in the back, which I think lots of patients think, ‘I’ve pulled a muscle! I was way silly, I shouldn’t have done that, I pulled a muscle’. I think it may be that osteoporotic fractures cannot necessarily be that painful when they start.

Some patients definitely describe a very sudden onset and severe pain when a vertebral fracture occurs. One of my patients was on holiday in New York. She’d never been to the States before. She stepped off a kerb and the sudden onset of pain in her back was so bad she thought she’d been shot. She thought it was more likely that she had been shot in New York then had broken a bone in her back when she thought about it. Sudden, absolute agony, the sudden onset pain, but I think is pretty unusual. The vast majority of people do not go to their GP or go to hospital with a vertebral fracture because it probably is not that painful and/or they expect back pain. I think it’s something within our culture that we expect as we get older [that] we’re going to get back pain. When we do something silly like pull a bin, or try and lift up a plant pot using a very bad posture, and we develop sudden onset pain in our back that’s not too bad, we think, ‘Oh, well, that’s my fault – I have pulled a muscle’. We just wait for it to get better, which it probably does, that acute pain, over about six weeks.

Evans: Is that okay? If I were putting out my bins and I twisted and I felt something in my back. Through 62 years of experience, I would think, ‘Ah, I’ve pulled a muscle, it’ll be okay’. Should we be going to the doctor then?

Clark: If we think about adults in general, the vast majority of situations like that will be a pulled muscle. But, perhaps in somebody who’s quite old and I don’t know what that means. I don’t want to put an age on it because we all age differently. But perhaps someone who’s frail; perhaps someone who’s got risk factors for osteoporosis (perhaps those who are on steroids for other diseases such as asthma, rheumatoid arthritis, bowel disorders and people who are heavy smokers), people who are frail. When people become quite thin, less mobile, have quite a few other illnesses, take many, many medications, that whole package. You know, it’s quite difficult to describe frailty, but we all recognise someone who is frail. Perhaps people who are frail who do that and develop sudden onset back pain or someone who’s on steroids, they should consider going to their GP or somebody within their practice, it may be another allied health professional such as a nurse or physiotherapist, just to be assessed to make sure they haven’t had a vertebral fracture.

Because having a vertebral fracture means you are at one of the highest risks of having another fracture, including a hip fracture, and hip fractures are completely devastating. If we can find people who have vertebral fractures, we can give medications to reduce the risk of future fractures. We can reduce the risk of a hip fracture by about half, all the evidence suggests. That is so important because hip fractures, for the individual, can be a disaster. I think 20% of people are not alive twelve months after their hip fracture, a third of people cannot go back to their living arrangements that they had before. They need additional help; they need to change living upstairs to downstairs; they need to go into nursing homes or more sheltered accommodation. And they are very expensive – they cost the NHS lots of money. We’ve got a very good medication that we can use to reduce that risk but, at the moment, less than a third of people with osteoporotic vertebral fractures are being identified through a variety of reasons, I have to say, but one of which I think is [that] we don’t really understand the typical story of somebody with an osteoporotic vertebral fracture. That’s why I’m focusing my research at the moment.

Evans: Well, what don’t we understand and what is your research?

Clark: One of the problems is that back pain is very, very common and people find it very, very uninteresting. By people, I mean family members, I mean doctors…, I mean…

Evans:It’s just another ache and pain.’

Clark: Absolutely, absolutely. When someone says, in a clinical situation, ‘I have back pain’. The most common reaction to that is, ‘Oh, and just note it down’ rather than saying, ‘Well, tell me about that. Where is it? What is it like? How does it start? What makes it worse? What makes it better?’

My research is really trying to find out is there a difference in back pain between someone with a vertebral fracture, and someone without. I think it’s clear that there is a difference. For example, people with back pain and osteoporotic vertebral fractures describe a chronic background pain that they describe as grinding, gnawing, a sort of a dull ache. It’s not necessarily in the centre of the back, it’s often a bit more around the sides. That is probably because when you have one or more broken bones in the back, the shape of your back has changed, the height of your back is shorter, you’ve shrunk a bit. All of the tissues, the muscles, the ligaments, the ribs are now in less space; your trunk has shrunk and changed. That gives sensations around the waist area that might be described as grinding or a dull ache.

We also find that there is a difference in the pain that happens with daily activities and movements. So patients with vertebral fractures describe pain in their back or trunk region building with activity and reaching a real crescendo or peak at which point they have to stop, and often lie down or recline backwards – so lean back and extend the spine to relieve the pain. The typical movements that contribute to this are standing up and leaning forward slightly and unfortunately that is sort of the position of work for humans. When we’re washing up, for example, or preparing food, or doing a jigsaw, or working on the keyboard, we’re leaning forward slightly, putting the weight of our upper torso and head on the front of our spine. For people with vertebral fractures, I think that is what is contributing to this crescendo or peak in pain.

The time to reaching this peak varies. It seems to be much shorter in people who are older, possibly because they have less muscular mass around their spine. Pain in people with vertebral fractures tends to improve enormously on lying down, so people with vertebral fractures often get quite a good night’s sleep. These descriptions are different to people who have back pain due to osteoarthritis, where often lying down is one of the worst times. Patients with osteoarthritis also tend to describe pain shooting down the legs or pain worse with cold and damp weather. Those two things don’t seem to occur in people with pain due to vertebral fractures.

Evans: That’s Consultant Rheumatologist Emma Clark. Sarah Leyland is a Nurse Consultant now working for the Royal Osteoporosis Society, a charity that provides information and support for people living with osteoporosis. It has many resources, including a specialist nurse team-lead helpline.

Sarah Leyland: Our aims are to make sure that people get the help that they need, certainly in terms of care. making sure people are diagnosed appropriately and get access to the appropriate medications and treatment in order to prevent fractures. We’ve got a new focus more recently on prevention, making sure that people who are younger, who are not yet affected by the condition are making lifestyle changes to keep their bones strong and get the best bones they can to put them in the best position before they lose bone in later life.

We’re also very interested in a model of care within the Health Service that’s picking up those people who are at the highest risk of further fractures. We’re supporting a model of care called Fracture Liaison Services where, when someone breaks a bone, they get a proper assessment to check out could this be related to osteoporosis. People [then] get assessed, they get treated and they get followed up in specialist teams. It’s making sure people are fed into that system.

We’re very interested in preventing fractures but we also have always had a role to play in terms of support, so people either wanting information, local support groups, peer support or coming through to our specialist helpline and getting access quite rapidly. We also support health professionals, so we run conferences, training programmes [to] try giving them them the tools they need to help them do their job.

Evans: What do people who contact your helpline worry about most?

Leyland: They’re worried obviously about the impact of osteoporosis on their future life – on both their day-to-day living and quality of life, but also that it might shorten their life. They’ve heard about people dying as a result of osteoporosis, so people ring us they’re fearful. They may have had a diagnosis, someone’s told them they’ve got osteoporosis and they want to know what the future will hold. They also often ring us if they’re worried about the drug treatments [or] the medicines – they don’t want to take them unless they really need to. They’ve heard about health risks associated with the medications. We talk a lot about that. Then at the other end of the continuum, we talk to people who’ve had fractures, particularly vertebral spinal fractures, who are living day-to-day with pain and symptoms and are struggling often and not getting the care and the help that they need.

Evans: If somebody were phoning you, and this might happen with lots of conditions, people really want that help at primary level, at GP level and they feel they’re not, perhaps not being taken seriously, perhaps not being listened to. How would you advise somebody to go back to a healthcare professional, a GP, and say, ‘Listen, please will you look at this? Please, I’m worried about this’?

Leyland: I think that’s where being informed makes people feel a bit more confident. That’s where the charity can be helpful because if people know a little bit more about the condition and what the options are, then they’re more ready.

We also encourage people to be, and this is the same as for any condition, to be prepared for their appointment because there’s so little time. Go in with your questions ready and sticking to those, perhaps writing things down, maybe taking someone with you if you don’t feel very confident. We can’t advise you what to do, but we can take you a bit further down the pathway. Help them to understand who might need a referral to a specialist because everybody doesn’t need to go to the hospital, but some people may benefit from that. Particularly younger people because the treatments and the care pathway is not so clear in a younger person.

Evans: Sarah Leyland of the Royal Osteoporosis Society. Now, earlier in this edition of Airing Pain, rheumatologist Emma Clark talked about her research into developing a method whereby it would be easier for health professionals in primary care (GPs that is) to identify a vertebral fracture as opposed to osteoarthritis.

Clark: The whole point of this research is to produce a very simple clinical tool. So, basically a checklist and it is absolutely aimed at GP practices – the first point of contact, whether that is a GP, a nurse or a physiotherapist. The goal is that in the next few years we will have this simple checklist. When an older person goes to their GP practice with back pain the healthcare professional produces this simple checklist and ask, ‘Have you previously broken a bone? Is your back pain worse when you lean forward? Is it better at night?’

I don’t know exactly what it’s going to include, because we’re currently doing the research. Ideally, this is going to be an app so it’s just done very quickly on the computer and the answer will come up ‘this person needs an X-Ray’ or ‘this person does not need an X-Ray’. It will recommend an X-Ray if the checklist has suggested this person may well have a broken bone in their back due to osteoporosis, so a vertebral fracture.

Evans: You mentioned earlier that [whilst osteoporosis] may not be reversed, perhaps the progress [could be] stalled or halted.

Clark: There are two pathways of management, of help, that should be given to people with an osteoporotic vertebral fracture. The first are interventions to improve their pain, their quality of life, their fatigue and posture. The second is, as you say, to reduce the risk of further fractures. So those large cells I talked about, those osteoclasts – that walk along the surface the bone and take a little bite out – we have a medication available that inhibits them.

Evans: What can we do earlier in life to manage our later life osteoporosis?

Clark: I think it’d be really helpful at this point to remind everybody that actually our peak bone mass is quite strongly determined by our genes, our genetics. Probably 80% of our peak bone mass is determined by the way we’re made. Osteoporosis is not our fault in the majority of situations but there are some things we can do to really optimise our peak bone mass, such as do not smoke, do not drink excess alcohol. It is alcohol excess that’s also associated with poor nutrition that is probably bad.

In terms of nutrition, daily protein intake and calcium intake is really important. As a growing person, we should have over one pint of milk per day or equivalent. As an adult, we should have one pint of milk per day or equivalent. Obviously, there are other fields that you can get calcium from that it’s not just dairy products. There are lots of really useful resources online, such as the Royal Osteoporosis Society, where people can go and identify if they’re getting enough calcium in their diet.

Vitamin D is also really important. Vitamin D is a vitamin that we get through the sun and it is not possible to get enough in a normal diet – we do need to expose our skin to the sun. This can be tricky, because of the other health messages of ‘Don’t burn’, because of the risk of skin cancer. There’s definitely a balance. Plus, also if somebody is poorly and can’t go outside, if somebody’s got dark skin, if somebody covers up for whatever reason, and therefore does not expose their skin to the sun, they should probably take vitamin D supplementation to ensure that they get enough vitamin D.

Part of our problem is also we live in the UK so it rarely gets enough sun and, occasionally, when the sun comes out it can be very fierce, so it’s a bit of an issue for us in the UK. So vitamin D supplementation is recommended to all adults probably over the age of 65/70, but also other people who don’t get enough vitamin D younger than that. Then [there’s] physical activity. Our bones are amazing and if we use them as we’re growing, they will grow stronger. Tennis players, for example, the hand that they hold their racket in, we can show on our scans that the bones are stronger than the hand they don’t hold the racket in. This makes sense: if you use it, it builds up; if you don’t use it, you lose it.

Evans: Rheumatologist Emma Clark. Bearing what she said in mind, Nurse Consultant Sarah Leyland of the Royal Osteoporosis Society has been developing exercise and physical activity resources for people with osteoporosis.

Leyland: The project that I’ve been working on is looking at what is the role of exercise for someone with osteoporosis. By osteoporosis I mean, in the widest sense, people who’ve got reduced bone strength, with or without fractures.

The project focused on [the] three main areas that exercise continued to be important [in]. It was important for maintaining muscle and, therefore, bone strength, or promoting maybe some improvements (though the evidence isn’t very clear). Secondly, exercise [is] really important in terms of improving balance and muscle strength to prevent you falling because if you don’t fall, then some of the fractures that we get with osteoporosis are never going to occur, so not falling is important. We talked about strong, steady and the third area was about straight. How exercise can help you with posture and help you [with] moving and lifting. That may help to reduce further spinal fractures simply by the sort of pressures you’re putting particularly on the front part of the spine. There are ways that exercise might help with the pain you may get after fractures. So there are some simple exercises we were providing which might help with the immediate pain problems, but the others that help to build up the muscles around the spine. The long-term problems that we get with osteoporosis are [that] after you’ve had a spinal fracture, it’s healed but the shape of your spine doesn’t go back to what it was. It’s often the muscle spasm, the ligament strain, perhaps even the pinching of nerves so it’s a more sort of complex problem than long-term pain but exercise can help there as well.

Evans: So you said strong, steady and straight?

Leyland: Yes, so these are just three words that we use to capture the different ways that exercise can help with osteoporosis. It was just trying to get people to, not only think about promoting bone strength, but think about preventing falls. [It’s] also to help people who are very fearful because one of the big things is that, particularly if you’ve had one fracture, you’re terrified that if you do anything, if you move, if you lift, you’re going to get another fracture. So, the whole project was about positivity and helping people to feel confident, to carry on life normally but with some small adaptations, or feeling that they could take control of it.

Evans: That’s Sarah Leyland of the Royal Osteoporosis Society. Before we end this edition of Airing Pain, I’ll just remind you that whilst we in Pain Concern believe the information and opinions on Airing Pain are accurate and sound, based on the best judgments available, you should always consult your health professional on any matter relating to your health and well-being. He or she is the only person who knows you, and your circumstances, and therefore the appropriate action to take on your behalf. You can find all the resources to support the management of chronic pain, including details of our helpline, videos, leaflets, all editions of Airing Pain and the Pain Matters magazine at painconcern.org.uk. For a wealth of information on how to live well with osteoporosis, go to the Royal Osteoporosis Society’s website which is theros.org.uk. Here’s the society’s Sarah Leyland to finish this edition of Airing Pain.

Leyland: We’ve got a new range of exercises, both fact sheets and video clips. So, you can go online and have a look at how to do the exercises. For instance, in the back pain section, you can read about how the exercises may help and you can see some simple diagrams about just two or three simple exercises that you can do straight away. Plus [there’s] a short video, for those who have a computer, [to] see how to do it and how to adapt according to where they are. So if they’ve got multiple fractures and they’re frail they can still do something. One of the things we hear is people quite often, even if they’ve had painful spinal fractures, might see the specialist, the rheumatologist who says, ‘I’ll give you a referral to the physio’, [but] they don’t get the referral for about six weeks [so] they sit at home. One woman told me the rheumatologist said, ‘Don’t do anything until you see the physio’ and she literally sat in the chair, sort of paralysed with anxiety. Whereas we try to give people quick access to information so they can, not only get the care they need, but they can do something now that might help them.


Contributors:

  • Dr Emma Clark, Rheumatology & Osteoporosis Consultant at North Bristol NHS Trust
  • Sarah Leyland, Osteoporosis Nurse Consultant at the Royal Osteoporosis Society.

More information:

Half a century worth of research exists on neuropathic pain but what are the latest developments?

To listen to this programme, please click here.

This edition of Airing Pain is facilitated by the neuropathic pain special interest group (NeuPSIG) of the International Association for the Study of Pain (IASP).

With the previous edition of Airing Pain focusing on the ‘psycho’ and ‘social’ of the bio-psycho-social model, this programme tackles the ‘bio’ component.

In this second instalment in a mini-series on neuropathic pain, Paul Evans delves into the latest scientific developments on the condition and the ways in which the gap between research and treatments could be bridged.

Following on from Airing Pain 115, which concentrated on targeted Pain Management Programmes, this edition discusses the ‘bio’ element on dealing with neuropathic pain. Speaking to Professor Srinivasa Raja, Paul discusses what exactly is going on in the brain with neuropathic pain. Professor Raja provides a valuable explanation of the science behind the condition.

Patrick M. Dougherty, Professor at the Department of Pain Medicine at The University of Texas MD Anderson Cancer Centre then shares with Paul the latest advances in neuropathic pain research. He examines the link between cancer treatments and the condition as well as the potential for treatments such as immunotherapy to combat neuropathic pain in the future.

Issues covered in this programme include: Neuropathic pain, the bio-psychosocial model, allodynia, nerve injury, post-herpetic neuralgia, pain after shingles, pain after amputation, differences between men and women, chemotherapy-related pain, cancer, multidisciplinary pain teams, and personalised pain management therapies. 


Paul Evans: This is Airing Pain, a programme brought to you by Pain Concern, the UK charity providing information and support for those of us living with pain, and for healthcare professionals. I’m Paul Evans, and this edition of Airing Pain has been supported by the International Association for the Study of Pain.

Patrick Dougherty: The idea that you could use immunotherapy for chronic neuropathic pain – that’s a completely new vista. This sort of research has only come up now over, like, the last three or four years. So this is a whole new vista.

Paul Evans: This is the second of two editions of Airing Pain about neuropathic pain, a condition caused by nerve disease or nerve damage. The biopsychosocial model for managing chronic pain recognises that the biological, psychological, and socio-environmental factors all feed into each other and affect the pain. And that’s why multi-discipline pain teams made up of psychologists, physiotherapists, occupational therapists, physicians and other disciplines can be so effective in helping people live with their pain.

In the previous edition, we looked at how the psychological and social elements of people’s neuropathic pain are addressed at the National Hospital for Neurology and Neurosurgery Pain Management Centre in London, and I recommend you listen to that. In this edition, I want to look at the biological component of the biopsychosocial trinity, and in particular, to the progress or otherwise, that’s been made into the understanding of neuropathic pain, and what developments and treatments might be just around the corner.

In May of this year, that’s 2019, the International Association for the Study of Pain brought together the world’s leading experts on neuropathic pain in London to share experience and knowledge. One of those is Professor Srinivasa Raja of Johns Hopkins School of Medicine, Baltimore, in the United States. He’s internationally recognised for his research into neuropathic pain.

Srinivasa Raja: One of the earlier things that we were seeing is that in patients who had nerve injuries, they had chronic pain, they would have pain long after their, quote-unquote, tissue injury healed. And they would come up with this sensation, where they would say, you know: ‘Just touching that area, or even rubbing of things bothered me.’ This phenomenon is called allodynia, or pain to sensations that are normally not painful. So we were wondering, you know, what could be causing this, you know, is it because of change in how the normal pain signalling nerves or pathways change? Or is it something else?

So we brought some of these patients, and a simple experiment we did was we applied a tourniquet around their arms. So, after the tourniquet, the sequence of loss of sensations in nerves of different sizes are variable. So the touch fibres are often lost first, and then the pain fibres. So as soon as these touch fibres were lost, you know, these patients lost the sensation of this hypersensitivity, which told us that what’s happened is, there were changes occurring at the level of the central nervous system, such that this touch sensation – which in the spinal cord at higher centres, has a common termination with where the pain fibres go – there were changes in the level of the spinal cord resulting in a phenomenon called central sensitisation. That is, it’s almost like the amplifier or the volume has been increased at the level of the central nervous system, such that now even kind of activating these fibres, which on normal individuals we would call as touch, now those individuals feel that as pain. So, this is one of the clinical aspects of understanding that injury to nerves changes how the central nervous system now perceives different sensations. And this also led to a lot of investigation by numerous investigators, looking specifically at the level of the spinal cord and even the brain, [at] what we now call the neuroplasticity [of the brain], or how these signalling mechanisms change. And now we know the molecular biology, we know a lot about it. And this has led also to possibly identifying targets for treating patients with this type of presentation.

Paul Evans: Let me go back a little bit to see if I understand this: a tourniquet on my arm, and I will lose touch sensation. Lots of us will have experienced that, [for example] when we say: ‘oh my foot has gone to sleep’. At what point do you stop the pain signal?

Srinivasa Raja: These patients, when they lost the sensation of touch, could still feel a pinprick, so their pain was still intact. But what they lost also was that hypersensitivity phenomenon where their touch resulted in the sensation of pain. And this is something we commonly see, particularly with patients with post-herpetic neuralgia or pain after shingles. You know, the common site for shingles is often the chest wall. And women are much more prone – two-to-one, almost – [to experience this] than men. And the common complaint that they’ll present to us is that [they] can’t wear a bra, you know, clothes are very uncomfortable. That rubbing of the clothes on that skin is very uncomfortable.

Paul Evans: Explain to me now – we’ve gone through the putting the tourniquet on and losing touch. What is going on in the brain with neuropathic pain?

Srinivasa Raja: This is a challenging question, because we’re talking about half the pain research community, working for almost half a century trying to understand this. The good news is that we have made enormous progress in understanding the science, the molecular biology, the neuro-physiology or the changes in the nervous system. The unfortunate sad news is, it hasn’t been translated into new treatments for patients with neuropathic pain. So there’s a big gap between the advances in research versus what we call translating that into new treatments for patients. A significant new area of research is to try to understand why this gap [exists] and what may be causing it. But to go back to answering your question, what we have understood is that changes occur at every level of the pain signalling pathway. In certain cases, this occurs at the level of the periphery at the site of injury itself. Again, I’ll come back to the amputation example, where a nerve is often cut at the time of the amputation. And these cut nerves form what’s called a neuroma, which is a nerve trying to grow back to its original site. And these neuromas are very sensitive, they are active, and they fire spontaneously, almost like seizure activity of a peripheral nerve. And these signals, [which are] constantly going from the periphery to the nervous system, are sending signals to the brain saying [that] there is a problem somewhere in the periphery. So the first thing – and this phenomena is called peripheral sensitisation, or changes in the peripheral nervous system. These, kind of, ongoing signals in turn cause changes at multiple levels in the central nervous system, at the level of the spinal cord, the level of the thalamus in the brain and the cortical levels, where this constant barrage of signals changes how the central nervous system perceives the signals. And it’s altered in a number of ways, which globally is called a central sensitisation. So this combination of peripheral and central sensitisation in various degrees can occur at different brain states.

Paul Evans: So with an amputation, those nerves [which are] firing off at the amputation, [are] looking for where they were, presumably, and [are] maybe overloading circuits in the brain?

Srinivasa Raja: You said that better than I explained. It is overloading the system in some ways, resulting in changes. Some of these changes seem to be more persistent than others. So, the struggle has been to see how we can revert this process, how we can reverse these changes occurring at the level of the central nervous system, and that’s been a significant area for research.

Paul Evans: That’s Professor Srinivasa Raja of Johns Hopkins School of Medicine in the United States. Professor Patrick Dougherty is professor of pain research at the MD Anderson Cancer Institute in Houston in the United States.

Patrick Dougherty: I’ve been interested in neuropathic pain, basically, ever since I was a postdoc or graduate student. And I was really very interested in how activation of the immune system impacts us in such a dramatic fashion. So imagine the last time you were really sick, how just godawful you felt, and that biology to me was extremely fascinating. Well, that carries straight over then into what happens to the nervous system following peripheral injury. And so, ultimately, that leads to what we know now is neuropathic pain. Any type of injury that either leads to some sort of a chronic maladaptive response in the nervous system, or direct injury to the nervous system that then leads to maladaptive responses, resulting in pain. Any of those would fit the category of what we call now neuropathic pain. And so, initially, our work was focused on trying to tie [in] specifically what we call psychophysics. Psychophysics means what people report when you apply energy to skin. And we want to model how human psychophysics is reflected in the activity of specific neurons within the central nervous system. And that was very successful, then led to an appointment at Johns Hopkins University, where I became interested there in changes in neurons in the brain related then to neuropathic pain.

That group of patients, now imagine the type of patient you’re looking at, they have neuropathic pain that has been inadequately treated to the point where they’re willing now to have a hole drilled in the top of their head, and put instrumentation inside their brain to try to treat this pain. This is how far down the road they’ve suffered, basically, and what they’re now willing to try. And [when] I’m looking at that I’m thinking, you know, these folks are so complicated, we’re never going to be able to figure out mechanisms in this condition. That then led me to think [about] neuropathic pain, [in which] we know the patient starts off basically normal, as far as pain goes, and then we cause neuropathic pain. And that’s those folks that are getting cancer treatments. Those people are basically neurologically fine. They had cancer, obviously, but they don’t have neuropathic pain. We know exactly what the insult is, it’s the cancer treatment. So the thought was, we could basically follow those people from before they get treatment, all the way to the end, [and then] we’ll be able to profile a whole natural history of neuropathic pain. Then we can start to come back to other folks that have neuropathic pain, we can stage them in and apply rational therapies. That was the idea.

Paul Evans: So you’re going down a known route, [which is] people with cancer, who’ve had treatment for their cancer. Some get neuropathic pain and some don’t. And you’re backtracking, then, for people who get neuropathic pain, and you don’t know where it started.

Patrick Dougherty: That’s basically the idea. It doesn’t really work out all that well. Because even cancer treatment-related neuropathic pain becomes very heterogeneous very quickly. In other words, there’s a lot of branch points in the road. And so again, to try to back up to anybody becomes complicated, but in any case, we can gain a lot of insights to the underlying mechanisms. And there’s been a particular advancement here lately, that is really exciting to us. And that is, we found that you have a group of neurons that innervate your skin, those are called primary efferent neurons. And those primary efferent neurons have cell bodies that basically are what give them sustenance, and metabolic support, and those are called dorsal root ganglion neurons. So the dorsal ganglion neurons are those that send their axons out to every tissue in your body.

What we discovered is that in basically every model of neuropathic pain now – and so this is where the road seems to converge – [in] every model of neuropathic pain that we’ve looked at so far, these dorsal root ganglion neurons become spontaneously active. They shouldn’t be spontaneously active, particularly if they’re a pain fibre. Pain fibres should be quiet, unless you’re having pain. To find out that if we give animals chemotherapy drugs, and we go in and deliberately injure nerves to try to produce a neuropathic condition, these dorsal root ganglion neurons become spontaneously active in animal models. Lo and behold, in the course of just simply talking to people at MD Anderson, it turns out that there’s a cohort of patients where their dorsal root ganglion neurons are going to be taken out in the course of trying to treat their cancer, so they get cancer into the spine, which is where near where the dorsal root ganglion lives, and sometimes to treat that cancer in the spine, those dorsal root ganglion neurons are taken out in order to get to the tumour.

What we found out is that if those ganglion neurons in human beings come from a part of the body where that patient is experiencing neuropathic pain, lo and behold, they are also spontaneously active. So now we can take animal models of the spontaneous activity, and we can directly line them up to the spontaneous activity that occurs in human neurons, and move back and forth, looking at those mechanisms that are shared or different between humans and the animals. This is really exciting, and a number of different labs now have confirmed that finding, and this is probably one of the biggest new movements in the field.

Paul Evans: Let me see if I can understand, ‘dorsal root ganglion’ – explain to me again what that is.

Patrick Dougherty: You may also hear it called, particularly in the UK, ‘posterior root ganglion’. The posterior root ganglion and the dorsal root ganglion are what are called the cell bodies; the centre of the neuron that leads to all of the peripheral endings that innervate your skin. So, when you move a hair on the back of your hand, there’s a neuron that’s back along your spinal cord that’s being activated by that. It has an axon that goes out and it wraps around the bottom of that hair cell, you move the hair, that causes that axon to discharge, that action potential goes back past the ganglion neuron and then into your spinal cord, [it] makes a synapse, [which is] a connection to another neuron. That then eventually sends that information to your brain and you realise: ‘Aha, a hair’s moving on the back of my hand, something’s happened!’ And then every sensation you can think of, for every part of your body, has a separate dorsal root ganglion neuron that has an ending in that part of the skin, muscle, bone, tendon, etc.

Paul Evans: So for cancer patients having treatment, that pathway was broken?

Patrick Dougherty: Not broken – let’s describe what happens to cancer patients when they get chemotherapy drugs. There’s a number of chemotherapy drugs, not every chemotherapy drug [results in neuropathic pain], but there’s many chemotherapy drugs. So for example, those used to treat breast cancer, prostate cancer, most every cancer of a solid tissue and some blood cancers, get sets of drugs that ultimately result in what’s called neuropathic pain. And what happens for all of these classes of drugs, and many people out there can attest to this. They probably will be nodding their head: ‘Yes, that’s me.’

You get these drugs, first, it leads to numbness in their hands, that progresses to tingling. That’s probably three quarters of patients [who] get those sensations as they get those drugs. And that’s fine. Again, mostly everybody’s going to get that, [and] mostly everybody that gets better. But [for] some of those patients, that numbness and tingling progresses to the point where their hands and feet feel like they’re on fire. Unfortunately, in about one-fifth of patients, that burning sensation, that numbness, that horrible pins and needles feeling, persists long after the cancer treatment’s over and now they would fall into the category of neuropathic pain patient.

Paul Evans: So you follow that track with certain patients having cancer treatment, and you try and replicate that.

Patrick Dougherty: Right, we can give animals chemotherapy drugs, though, we have to change our measurements a little bit, because obviously, the animals can’t tell us that they have ongoing pain, but there’s different behavioural measurements that we can put the animal in. So for example, folks that have gotten Taxol, often what they’ll tell you is that cold applied to their skin feels like it’s burning. So you can give animals Taxol, now put them in a little room, and you [make] part of the floor cold, and part of the floor [not cold], and what you’ll see is that the animal won’t go over to the cold floor, it’ll stay over on the warm floor. But since again, [with] the behaviour in the animal, you’re always kind of guessing what that means. I’m always really interested in what we can objectively measure. And that’s why I say when we find that you get this ectopic spontaneous activity of the neurons that otherwise should be quiet. And you can see the same thing in people. That’s what I like to zero in on, we don’t have to guess what it means: either that cell is discharging, it’s on, or it’s off. And then [with] people it’s either on or it’s off. And if we can figure out how to take the cells that are on and make them shut off, then the idea is that that’s what’s going to relieve their symptoms.

Paul Evans: Go on, then, can you?

Patrick Dougherty: We are making a lot of interesting progress. So the physiology gets to be really complicated really fast. But there are a number of potential therapeutic avenues that have been uncovered, that now we need to figure out how can we operationalize. There’s questions that have arisen that are very surprising. So there’s a paper we published a month ago or so, where what we did in that paper – we had these human neurons. In my lab, we did the physiology, and we determined which of these ganglion neurons that we had were in samples associated with pain and with the spontaneous activity. The human ganglion is big enough that we could divide it, and we can share part of that tissue with another laboratory in Dallas, headed by a fellow named Ted Price. Ted’s group broke those ganglion neurons apart and started looking at what we call their transcriptome. And the transcriptome is basically an output from their DNA. In other words, what part of the DNA were those cells activating, that we think would be related to the generation of the spontaneous activity. So we wanted to know, then what sorts of proteins are being made that either weren’t made before, or that used to be made that aren’t any longer being made. Again, the idea that we can reveal potential new therapeutic targets. And so, Ted did all this analysis. And what we did initially is we took all the ganglion neurons that we had from dermatomes, or segments of the body where patients had pain. And we compared the genetic information coming from all of the neurons from dermatomes without pain. And we run the analysis, and lo and behold, we got almost nothing, we couldn’t believe that – that couldn’t possibly be the right answer. Finally, we decided, you know, let’s just go ahead and we’ll pull all the women out, we’ll just separate men from women.

Then what we did was, we ran all of the neurons from men, segment pain; men segment no pain, and voila, we got a huge number of results. What that tells us is that men and women are actually changing different gene signals differentially with pain. So in other words, men are from Mars, and women are from Venus. In fact, we have quite distinct mechanisms by which our bodies, in this case, our neurons, respond to this insult – the toxic chemotherapy drug that then results in different ways of expressing pain. Now, what [does] that therapeutically mean? Well, that means that if you give a given drug to a man, that might work, [but] that same drug given to a woman may not. And then if you further follow the logic to that, even for a given man, there’s going to be variability within the male cohort. So even a drug that works in man number one may not work in man number two. It’s leading to the prospect that what we’re really going to need to do is come up with sets of what we call biomarkers, and these gene signals are a type of biomarker, there’s others. But we’re going to probably need to get sets of biomarkers for each person, and then thereby come up with specific therapeutics for each individual person.

Paul Evans: Wow, how or when will that impact on people with neuropathic pain?

Patrick Dougherty: That’s a hugely convoluted question, I think, you know. So number one, there are numbers of compounds that are out there that are available now. Most pain clinics have a set of drugs, and they try different sets for different patients. Some folks respond to one type of agent, others respond to another. So the pain clinics already understand that you have to tailor each pain therapy specifically to each patient. So that concept is already in place. What our research is showing is that we need a broader palette of therapeutics to address given folks, my lab is not alone in this approach. So there are a number of labs here in the UK that also are doing very similar work to us, in that they’ve got the same tissues, they’re also doing these same kinds of analyses. And one of the other things that we’ve discovered in these ganglion neurons that’s really important is that part of what causes these neurons to become active, is that when the ganglion becomes damaged, becomes inflamed, you get immune cells that go in there – and this is kind of funny, because it closes the loop on my whole career – that’s what it began with: how immune cells impact the brain.

It turns out that these ganglion become infiltrated by sets of immune cells, some are your angry uncle, and others are your soothing grandmother. And you can actually train the grandmother cells to go in and quiet everything down. And so with that idea being that you have immune cells that actually get into the ganglion that can either make things worse or better with one potential biomarker, and there’s other labs that are doing this, you could take a blood test, and from what’s in your blood – the immune cells that are in your blood – you may be able to get a picture of what potentially has gone into your ganglion that’s either driving that disease or that we can manipulate to try to make that disease go away. So the idea that you could use immunotherapy for chronic neuropathic pain, that’s a completely new vista that again, has been revealed by these new studies on ganglia and what’s going on in those ganglia.

So this sort of research has only come up now over like the last three or four years. So this is a whole new vista and what we simply need to do now is build up the sample sizes, I would say, you know, optimistically, as rapidly as biotech and the rest is advanced, let’s say five years, we can start actually having some real insights of what may be really good players to follow. And then it will be up to the pharma outfits and the new biotech outfits to operationalize those targets and come up with therapeutics. My side of the ledger is what’s called target identification. Once you get targets that are well validated, then you get into the legalistic part of bringing a drug to market. And so, I can’t tell you how long that might take based on which government you’re working with. If it’s in the US, it can be very slow, other countries move faster. So it’s hard to predict once you get into the actual regulatory process for each place, but I think as far as target identification goes, I would say within five years, we are going to have a very good idea of some promising new targets. I would say today, you know, our data says that a number of those that we could follow, but we need to validate the targets that we’ve identified. Other labs are identifying other targets, those should be mature enough, within five years, that you could start to operationalize those into therapeutics, and then you get into the therapeutic regulatory process, so that I can’t give you a handle on.

Paul Evans: That sounds very exciting, very positive. I guess it shouldn’t really come as a surprise that the same drug will work differently on different individuals. When we open our tablets, we see the list of the side effects, which could be diarrhoea, it could be constipation, it could be one of a hundred things, you know. Personalising designer drugs sounds really exciting.

Patrick Dougherty: Yeah, and it goes beyond just drugs, right? People need to be aware that pain, particularly a chronic pain condition, is not probably going to be treated by any magic-bullet drug. I mean, you’re going to need to go into whatever you can possibly do, that might work for you. Is that walking? Is it swimming? Is it yoga? Is it meditation? You know, there’s a whole number of different – both medical or drug – therapies and then non-medical therapies.

So MD Anderson, that is one of the pain treatment centres – what’s called a multidisciplinary pain centre – where basically whatever works for a given patient is what you’re going to try. And it’s probably not going to be one thing, there’s probably not one magic bullet. Number one, the patient has to decide they want to get better. It’s all about patient buy in: if you give up, the chances of being fixed are small. So you have to be focused, that you are going to get better, this is a disease you’re going to overcome. Then you find the combination of medications that work, the combination of exercise, the combination of nutrition, etc., that works for you to get you back, so that you’re in the game and you’re functional again.

Paul Evans: That’s Professor Patrick Dougherty, of MD Anderson Cancer Institute in Houston. And I was speaking to him and Professor Srinivasa Raja, at the International Association for the Study of Pain Neuropathic Pain Special Interest Group conference earlier this year, in London. I will just remind you that whilst we in Pain Concern believe the information and opinions on Airing Pain are accurate and sound, based on the best judgments available, you should always consult your health professional on any matter relating to your health and wellbeing. He or she is the only person who knows you and your circumstances and, therefore, the appropriate action to take on your behalf.

Well, in this edition of Airing Pain, we’ve been focusing on the ‘bio’: the biological elements of the biopsychosocial model for chronic pain. And please do listen to the previous edition of Airing Pain to learn more about these psychological and social elements.

Patrick Dougherty: They’re crucial. They’re absolutely crucial. If a person has chronic pain, and they become socially withdrawn, isolated, that quickly leads to depression, and an erosion of the spirit. And that person then is going to suffer even more. You have to get yourself back engaged into social environments, working as hard as you can to get yourself back to a normal level of activity. Meanwhile, we’ll be in the lab trying to come up with as many magic bullets as we can come up with. But I would be very surprised if we find anything that I say is the golden ticket, so to speak. It’s going to be a combination of things. Everyone’s going to have to sort out what specifically is going on with them in concert with their medical providers. What we’re hoping to do is come up with the tools and resources that, number one, we can [use to] better ascertain for that particular person what’s going on with them. And then, again, have the agents that can be then implemented.


Contributors:

  • Patrick M. Dougherty, Professor at the Department of Pain Medicine, Division of Anaesthesiology and Critical Care, The University of Texas MD Anderson Cancer Centre, Houston.
  • Professor Srinivasa Raja (John Hopkins School of Medicine, USA).

More information:

After a successful AGM on Thursday 7 November, it was announced that Heather Wallace has stepped down from the trustee board as part of Pain Concern’s ongoing restructure at board level. She will stay on as general manager, overseeing the day to day running of the charity.

Elections took place for the new trustee board and the new members elected are as follows:

  • John Finch
  • Martin Dunbar
  • Sue Peacock
  • Robin Aitchison
  • Mick Serpell
  • Heather Muncey
  • Cameron Werner

We will publish full biographies of the new trustee board in due course.

Black Friday and Cyber Monday will soon be here, which means digital subscriptions to Pain Matters magazine will be 35% off between 25 November and 8 December over at Pocketmags.com.

Also coming up is out Mega Sale! which will run between 26 December and 12 January, during which you can save a huge 30% off an annual suscription.

If that wasn’t enough, there will also be a 99p Flash Sale happening between 24-27 January, where you can purchase any of our available back issues for, yes, you guessed it, only 99 pence.

Missed an issue of Pain Matters? Fear not. You can now buy a selection of back issues via our website.

Click here for more details

Please note: these magazines are only available to people in the UK and while stocks last. For customers outside the UK, or for a wider selection of issues, please visit our digital store at pocketmags.com/pain-matters-magazine.

Experts by Experience, a new Airing Pain episode recorded live at the British Pain Society’s special interest group on pain management programmes, is out now.

This episode looks at the psychological benefit to patients, and the professional value to healthcare trusts, of patient-volunteers working within pain management programmes.

Listen to the episode below:

For a full description of the episode, click here.

Patient volunteers and healthcare professionals on working together in pain management programmes

This edition of Airing Pain has been supported by a grant from the Plum Trust.

In September, the British Pain Society’s special interest group on pain management programmes held their annual conference. A workshop entitled ‘Experts by Experience – Working Together in Pain Management Programmes’ was run in parallel to this. The symposium brought together patient-volunteers and healthcare professionals from four pain management centres around the UK to share their experience of working together.

Dr Nick Ambler, Consultant Clinical Psychologist of the North Bristol NHS Trust’s Pain Management Programme (PMP), facilitated the workshop; chairing an uplifting, frank and empowering discussion on the psychological benefit to patients and the professional value to healthcare trusts of patient-volunteers working within pain management programmes. This special extended edition of Airing Pain comes to you live from the conference, letting you sit in on the discussion.

Patient-volunteer Primrose Granville opens by giving a funny, relatable and inspiring testimony of how volunteering with her PMP has transformed and empowered her life and experience of pain.

Dr Debbie Joy, Clinical Psychologist and Clinical Lead of Pain Services for NHS Solent Trust, addresses some of the initial anxieties she had around the introduction of patient-volunteers to a clinical setting, but ultimately asserts that they are ‘definitely stronger with experts by experience by their side’.

Pain coaches for NHS Dorset – Penny and Debbie – offer constructive advice for professionals and volunteers on how you pain coach and engage with people living with pain effectively and sympathetically.

The founder of Glasgow Community Pain Education Sessions – John Bremner, talks about how this model of expert by experience in action works, and how they run it ethically and effectively. Lindsay talks about how rewarding an experience it has been, volunteering as a pain trainer for this initiative, encouraging others to get involved.

The symposium ends with the group sharing their experiences and insights in an open floor discussion.

Contact your GP or relevant pain management programme if you are interested in volunteering.

Issues covered in this programme include: Peer support, communicating pain, community healthcare, confidence, employment, gabapentin, laughing yoga, osteoarthritis, patient volunteer, Scottish parliament, support group, training course, volunteering and workshops.


Contributors:

  • Dr Nick Ambler, Consultant Clinical Psychologist for the North Bristol NHS Trust’s Pain Management Programme
  • Primrose Granville, person living with pain and patient volunteer with the North Bristol NHS Trust Pain Management Programme
  • Dr Deborah Joy, Clinical Psychologist and Clinical Lead of Pain Services for the NHS Solent Trust
  • Penny and Debbie, pain coaches for the Dorset NHS Trust
  • John Bremner, person living with pain, pain trainer and founder of Glasgow Community Pain Education Sessions
  • Lindsay, person living with pain and pain trainer for Glasgow Community Pain Education Sessions
  • Dr Martin Dunbar, Clinical Lead and Consultant Psychologist for NHS Great Glasgow and Clyde.

The BPS special interest group ‘Experts by Experience” workshop
The BPS special interest group ‘Experts by Experience” workshop

More information:

1 2 3 4 5 32
https://painconcern.org.uk/cordless-car-vacuum-cleaner-eraclean-best-handheld-vacuum/
https://painconcern.org.uk/cordless-car-vacuum-cleaner-eraclean-best-handheld-vacuum/ https://painconcern.org.uk/sex-toys-in-india-best-adult-products-online-sex-toys-store-for-men-woman/